ArticleJGH open : an open access journal of gastroenterology and hepatology2025

Self-Injection Satisfaction and Safety of CT-P17 (Yuflyma), a High-Concentration Adalimumab Biosimilar, in Patients With Crohn's Disease: A Cross-Sectional Study.

Fei Yang Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.